The potential for the research now being addressed by the Center for Multifunctional Biomolecular Drug Design (CEMBID) at Aarhus University is enormous.

The goal is to create a new generation of drugs that can be used to diagnose and treat cancer and atherosclerosis - which together represent two thirds among the causes of death globally.

The author presented on this page has recently published his 10th article since 2017 in Angewandte Chemie:

“Docking of Antibodies into the Cavities of DNA Origami Structures”: X. Ouyang, M. De Stefano, A. Krissanaprasit, A. L. B. Kodal, C. Bech Rosen, T. Liu, S. Helmig, C. Fan, K. V. Gothelf, Angew. Chem. Int. Ed. 2017, 56, 14423; Angew. Chem. 2017, 129, 14615.

DNA nanotechnology has the power to form self-assembled and well-defined nanostructures, such as DNA origami, where the relative positions of each atom are known with subnanometer precision.

According to tradition professor, Thomas LaBean from North Carolina State University, Department of Materials Science and Engineering, is visiting…